TRANSITION AGREEMENTTransition Agreement • March 17th, 2020 • Assertio Therapeutics, Inc • Pharmaceutical preparations • California
This Transition Agreement (this “Agreement”) is entered into by and between Arthur Higgins (“Executive”) and Assertio Therapeutics, Inc., a Delaware corporation (“Assertio”) and is dated as of March 16, 2020. The Executive and the Company shall collectively be referred to herein as the “Parties.”
VOTING AND SUPPORT AGREEMENTVoting and Support Agreement • March 17th, 2020 • Assertio Therapeutics, Inc • Pharmaceutical preparations • Delaware
This Voting and Support Agreement, dated as of March 16, 2020 (this “Agreement”), among Alligator Zebra Holdings, Inc., a Delaware corporation (“Parent”), and the stockholders of Zyla Life Sciences, a Delaware corporation (the “Company”) listed on Schedule A hereto (each, a “Stockholder” and, collectively, the “Stockholders”).
